155 related articles for article (PubMed ID: 36719293)
1. Diagnosis of Clinically Significant Portal Hypertension Using CT- and MRI-based Vascular Model.
Wang C; Huang Y; Liu C; Liu F; Hu X; Kuang X; An W; Liu C; Liu Y; Liu S; He R; Wang H; Qi X
Radiology; 2023 Apr; 307(2):e221648. PubMed ID: 36719293
[TBL] [Abstract][Full Text] [Related]
2. Deep Convolutional Neural Network-Aided Detection of Portal Hypertension in Patients With Cirrhosis.
Liu Y; Ning Z; Örmeci N; An W; Yu Q; Han K; Huang Y; Liu D; Liu F; Li Z; Ding H; Luo H; Zuo C; Liu C; Wang J; Zhang C; Ji J; Wang W; Wang Z; Wang W; Yuan M; Li L; Zhao Z; Wang G; Li M; Liu Q; Lei J; Liu C; Tang T; Akçalar S; Çelebioğlu E; Üstüner E; Bilgiç S; Ellik Z; Asiller ÖÖ; Liu Z; Teng G; Chen Y; Hou J; Li X; He X; Dong J; Tian J; Liang P; Ju S; Zhang Y; Qi X
Clin Gastroenterol Hepatol; 2020 Dec; 18(13):2998-3007.e5. PubMed ID: 32205218
[TBL] [Abstract][Full Text] [Related]
3. Quantification of Liver Surface Nodularity at CT: Utility for Detection of Portal Hypertension.
Sartoris R; Rautou PE; Elkrief L; Pollorsi G; Durand F; Valla D; Spahr L; Terraz S; Soubrane O; Cauchy F; Vilgrain V; Ronot M
Radiology; 2018 Dec; 289(3):698-707. PubMed ID: 30179109
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a radiomics signature for clinically significant portal hypertension in cirrhosis (CHESS1701): a prospective multicenter study.
Liu F; Ning Z; Liu Y; Liu D; Tian J; Luo H; An W; Huang Y; Zou J; Liu C; Liu C; Wang L; Liu Z; Qi R; Zuo C; Zhang Q; Wang J; Zhao D; Duan Y; Peng B; Qi X; Zhang Y; Yang Y; Hou J; Dong J; Li Z; Ding H; Zhang Y; Qi X
EBioMedicine; 2018 Oct; 36():151-158. PubMed ID: 30268833
[TBL] [Abstract][Full Text] [Related]
5. Virtual Hepatic Venous Pressure Gradient with CT Angiography (CHESS 1601): A Prospective Multicenter Study for the Noninvasive Diagnosis of Portal Hypertension.
Qi X; An W; Liu F; Qi R; Wang L; Liu Y; Liu C; Xiang Y; Hui J; Liu Z; Qi X; Liu C; Peng B; Ding H; Yang Y; He X; Hou J; Tian J; Li Z
Radiology; 2019 Feb; 290(2):370-377. PubMed ID: 30457484
[TBL] [Abstract][Full Text] [Related]
6. Splenic T
Hectors SJ; Bane O; Stocker D; Carbonell G; Lewis S; Kennedy P; Schiano TD; Thung S; Fischman A; Taouli B
J Magn Reson Imaging; 2020 Sep; 52(3):787-794. PubMed ID: 32073207
[TBL] [Abstract][Full Text] [Related]
7. Performance of liver surface nodularity quantification for the diagnosis of portal hypertension in patients with cirrhosis: comparison between MRI with hepatobiliary phase sequences and CT.
De Vos N; Sartoris R; Cauchy F; Rautou PE; Vilgrain V; Ronot M
Abdom Radiol (NY); 2020 Feb; 45(2):365-372. PubMed ID: 31797023
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Value of Portal Vein Velocity for Portal Hypertension in Patients with Hepatitis B Virus-related Cirrhosis.
Liu C; Chen S; Yan X; Xiang Y; Hui J; Liu Z; Yu Q; Li Y; Qi R; Liu Y; Bai X; Gao Y; An W; Dong J; Shen W
Curr Med Imaging; 2021; 17(11):1363-1368. PubMed ID: 33632109
[TBL] [Abstract][Full Text] [Related]
9. MR elastography outperforms shear wave elastography for the diagnosis of clinically significant portal hypertension.
Kennedy P; Stocker D; Carbonell G; Said D; Bane O; Hectors S; Abboud G; Cuevas J; Bolster BD; Friedman SL; Lewis S; Schiano T; Bhattacharya D; Fischman A; Thung S; Taouli B
Eur Radiol; 2022 Dec; 32(12):8339-8349. PubMed ID: 35727321
[TBL] [Abstract][Full Text] [Related]
10. Correlation of transient elastography with hepatic venous pressure gradient in patients with cirrhotic portal hypertension: A study of 326 patients from India.
Kumar A; Khan NM; Anikhindi SA; Sharma P; Bansal N; Singla V; Arora A
World J Gastroenterol; 2017 Jan; 23(4):687-696. PubMed ID: 28216976
[TBL] [Abstract][Full Text] [Related]
11. [Risk factors of clinically significant portal hypertension in patients with compensated liver cirrhosis based on hepatic venous pressure gradient].
Jiang FR; Yan HD
Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):995-1000. PubMed ID: 34814395
[No Abstract] [Full Text] [Related]
12. Plasma Nogo-A and placental growth factor levels are associated with portal hypertension in patients with liver cirrhosis.
Gelman S; Salteniene V; Pranculis A; Skieceviciene J; Zykus R; Petrauskas D; Kupcinskas L; Canbay A; Link A; Kupcinskas J
World J Gastroenterol; 2019 Jun; 25(23):2935-2946. PubMed ID: 31249451
[TBL] [Abstract][Full Text] [Related]
13. The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data.
Hong WK; Kim MY; Baik SK; Shin SY; Kim JM; Kang YS; Lim YL; Kim YJ; Cho YZ; Hwang HW; Lee JH; Chae MH; Kim HA; Kang HW; Kwon SO
Clin Mol Hepatol; 2013 Dec; 19(4):370-5. PubMed ID: 24459641
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive diagnosis of portal hypertension using gadoxetate DCE-MRI of the liver and spleen.
Hectors SJ; Bane O; Kennedy P; Cuevas J; Thung S; Fischman A; Friedman SL; Schiano TD; Taouli B
Eur Radiol; 2021 Jul; 31(7):4804-4812. PubMed ID: 33411050
[TBL] [Abstract][Full Text] [Related]
15. Endogenous motion of liver correlates to the severity of portal hypertension.
Gelman S; Sakalauskas A; Zykus R; Pranculis A; Jurkonis R; Kuliavienė I; Lukoševičius A; Kupčinskas L; Kupčinskas J
World J Gastroenterol; 2020 Oct; 26(38):5836-5848. PubMed ID: 33132638
[TBL] [Abstract][Full Text] [Related]
16. Novel serum biomarker of Golgi protein 73 for the diagnosis of clinically significant portal hypertension in patients with compensated cirrhosis.
Liu S; Ma J; Chen P; Liu S; Guo Y; Tan M; Guo X; Feng Y; Wang Q; Li W; Yang C; Gao B; Hua Y; Liu N; Song H; He R; Wang R; Gao Q; Liu C; Qi X
J Med Virol; 2024 Jan; 96(1):e29380. PubMed ID: 38235849
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive Evaluation of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis: The Role of Contrast-Enhanced Ultrasound Perfusion Imaging and Elastography.
Zocco MA; Cintoni M; Ainora ME; Garcovich M; Lupascu A; Iezzi R; Annichiarico BE; Siciliano M; Riccardi L; Rapaccini GL; Grieco A; Pompili M; Gasbarrini A
Ultraschall Med; 2023 Aug; 44(4):428-435. PubMed ID: 36526267
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension.
Lens S; Baiges A; Alvarado-Tapias E; LLop E; Martinez J; Fortea JI; Ibáñez-Samaniego L; Mariño Z; Rodríguez-Tajes S; Gallego A; Bañares R; Puente Á; Albillos A; Calleja JL; Torras X; Hernández-Gea V; Bosch J; Villanueva C; García-Pagán JC; Forns X
J Hepatol; 2020 Dec; 73(6):1415-1424. PubMed ID: 32535060
[TBL] [Abstract][Full Text] [Related]
19. Derivation and Validation of a Model to Predict Clinically Significant Portal Hypertension Using Transient Elastography and FIB-4.
Banini BA; Patel S; Yu JW; Kang L; Bailey C; Strife BJ; Siddiqui MS; Patel V; Matherly SC; Lee H; Lewis S; Cherian R; Stravitz RT; Luketic V; Sanyal AJ; Sterling RK
J Clin Gastroenterol; 2023 Feb; 57(2):189-197. PubMed ID: 34999644
[TBL] [Abstract][Full Text] [Related]
20. Shear-wave elastography: a noninvasive tool for monitoring changing hepatic venous pressure gradients in patients with cirrhosis.
Choi SY; Jeong WK; Kim Y; Kim J; Kim TY; Sohn JH
Radiology; 2014 Dec; 273(3):917-26. PubMed ID: 25025464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
